Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 20.75B | 19.53B | 21.31B | 22.78B | 18.59B |
Gross Profit | 13.76B | 12.66B | 13.95B | 16.01B | 13.48B |
EBITDA | 6.24B | 5.51B | 6.25B | 8.41B | 7.13B |
Net Income | 3.57B | 3.39B | 4.94B | 6.87B | 7.44B |
Balance Sheet | |||||
Total Assets | 35.73B | 36.19B | 35.52B | 31.48B | 28.32B |
Cash, Cash Equivalents and Short-Term Investments | 19.00B | 19.15B | 19.11B | 17.18B | 16.41B |
Total Debt | 1.08B | 1.64B | 1.50B | 1.11B | 1.42B |
Total Liabilities | 8.32B | 9.86B | 10.04B | 9.08B | 9.14B |
Stockholders Equity | 25.93B | 24.94B | 23.99B | 20.92B | 17.75B |
Cash Flow | |||||
Free Cash Flow | 2.68B | 2.61B | 3.80B | 4.80B | 6.89B |
Operating Cash Flow | 4.18B | 4.15B | 6.28B | 6.81B | 7.75B |
Investing Cash Flow | -1.32B | 386.70M | -4.80B | -2.44B | -3.79B |
Financing Cash Flow | -3.03B | -2.71B | -1.98B | -4.25B | -2.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $21.01B | 14.53 | -7.26% | 3.13% | 3.36% | -7.91% | |
55 Neutral | HK$41.84B | 10.80 | 14.06% | 6.54% | 4.18% | 3.39% | |
― | $8.69B | 14.33 | 25.49% | 4.63% | ― | ― | |
― | $12.86B | 8.02 | 15.40% | 8.61% | ― | ― | |
― | $8.15B | 560.81 | 0.21% | 2.94% | ― | ― | |
― | $8.04B | 14.07 | 32.58% | 3.26% | ― | ― | |
62 Neutral | HK$4.48B | 17.54 | 4.14% | 2.38% | -1.56% | 30.87% |
China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products offered by SPD Bank, investing RMB300 million using idle funds. This strategic move aims to enhance the company’s capital gains while maintaining low risk, as the expected returns from these investments are higher than those from conventional savings or time deposits. The company has ensured that this investment will not impact its working capital or operations, aligning with its core objectives of capital safety and liquidity.
The most recent analyst rating on (HK:6186) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
China Feihe Limited has issued a profit warning, indicating a decline in revenue and net profit for the first half of 2025 compared to the same period in 2024. This decrease is attributed to several factors, including childbirth subsidies, inventory adjustments to maintain product freshness, reduced government grants, and impairment provisions for milk powder products. Despite these challenges, the company expects a slight revenue increase by the end of 2025. Additionally, China Feihe has announced a share repurchase plan, intending to buy back shares using at least RMB1 billion from existing cash reserves, which will be used for future sales or employee incentives.
The most recent analyst rating on (HK:6186) stock is a Buy with a HK$6.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
China Feihe Limited has adopted the terms of reference for its Nomination Committee, which is part of its Board of Directors, as of June 24, 2025. This move is aimed at enhancing the governance structure of the company by clearly defining the roles and responsibilities of the Nomination Committee, which is crucial for maintaining compliance with the Listing Rules of the Hong Kong Stock Exchange.
The most recent analyst rating on (HK:6186) stock is a Buy with a HK$6.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
China Feihe Limited held its Annual General Meeting on May 29, 2025, where all proposed resolutions were passed by poll. Key resolutions included the adoption of financial statements, declaration of a final dividend, re-election of directors, and the reappointment of Ernst & Young as auditors. The meeting also granted the board mandates to repurchase shares and issue additional shares, reflecting strong shareholder support and strategic positioning for future growth.
The most recent analyst rating on (HK:6186) stock is a Buy with a HK$6.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products from SPD Bank worth RMB200 million using idle funds. This strategic move aims to enhance the company’s capital gain by utilizing temporary idle funds effectively, offering a higher return than typical savings or time deposits. The subscription is aligned with the company’s core objectives of ensuring capital safety and liquidity, and it is considered to have low risk while being beneficial for the company’s shareholders.
The most recent analyst rating on (HK:6186) stock is a Buy with a HK$6.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to a financial product offered by SPD Bank, utilizing RMB150 million of its idle funds. This strategic move is aimed at enhancing the company’s capital gains while ensuring capital safety and liquidity. The subscription is expected to yield a higher return compared to standard savings or time deposits, aligning with the company’s core objectives and benefiting its shareholders.
The most recent analyst rating on (HK:6186) stock is a Buy with a HK$6.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
China Feihe Limited has announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to a financial product offered by SPD Bank, utilizing RMB150 million of its idle funds. This strategic move is aimed at enhancing the company’s capital gains with a low-risk investment, offering a higher return than typical savings or time deposits. The transaction is deemed fair and reasonable, aligning with the company’s objectives of capital safety and liquidity, without affecting its working capital or operations.